details of ligand-induced receptor dimerization. An exception is the case of human growth hormone (hGH) binding Receptor dimerization is generally considered to be to its receptor (hGH-R). The hGH ligand is monomeric, the primary signaling event upon binding of a growth yet forms a 1:2 (ligand:receptor) complex with its receptor factor to its receptor at the cell surface. Little, however, (Cunningham et al., 1991) . Crystallographic studies of is known about the precise molecular details of ligandthe complex between hGH and the hGH-R extracellular induced receptor dimerization, except for studies of domain have shown that a single molecule of hGH binds the human growth hormone (hGH) receptor. We have analyzed the binding of epidermal growth factor (EGF) simultaneously to two receptor molecules (de Vos et al., to the extracellular domain of its receptor (sEGFR) 1992). A sequential binding model has been proposed, in using titration calorimetry, and the resulting dimerizwhich hGH binds first to one receptor molecule to form ation of sEGFR using small-angle X-ray scattering. a 1:1 complex. This complex then binds to a second, EGF induces the quantitative formation of sEGFR unliganded, receptor through a second binding site on dimers that contain two EGF molecules. The data hGH plus receptor-receptor contacts (Cunningham et al., obtained from the two approaches suggest a model in 1991; Fuh et al., 1992; Kossiakoff et al., 1994 ; Wells, which one EGF monomer binds to one sEGFR mon -1996) . The mechanism of hGH-induced hGH-R dimerizomer, and that receptor dimerization involves subation is thought to represent a paradigm for receptor sequent association of two monomeric (1:1) EGFactivation by other monomeric cytokines (Sprang and sEGFR complexes. Dimerization may result from Bazan, 1993) . Erythropoietin (EPO), for example, utilizes bivalent binding of both EGF molecules in the dimer a broadly similar mechanism (Philo et al., 1996a) , although and/or receptor-receptor interactions. The requiregranulocyte colony-stimulating factor (G-CSF) is an ment for two (possibly bivalent) EGF monomers distinexception, apparently being a monomeric monovalent guishes EGF-induced sEGFR dimerization from the ligand (Horan et al., 1996) .
hGH and interferon-γ receptors, where multivalent
In addition to the results with hGH, crystallographic binding of a single ligand species (either monomeric or views of ligand-induced receptor oligomerization have dimeric) drives receptor oligomerization. The proposed been obtained for the dimeric cytokine interferon-γ (IFNmodel of EGF-induced sEGFR dimerization suggests γ) bound to the α-chain of its receptor (Walter et al. , possible mechanisms for both ligand-induced homo-1995), and for the tumor necrosis factor (TNF-β) trimer and heterodimerization of the EGFR (or erbB) family bound to the extracellular domain of its receptor (Banner of receptors.
Introduction
taneously to two receptor molecules (Heldin et al., 1989; Fretto et al., 1993) . The neurotrophins are also dimeric, Induction of receptor oligomerization upon ligand binding is the first step in the activation of growth factor receptors with a single dimer binding to two receptors (Philo et al., 1994) , and stem cell factor (SCF) is a non-covalent dimer of four-helix bundle protomers that binds simultaneously to two molecules of its receptor, Kit, thus inducing Kit dimerization (Lev et al., 1992; Philo et al., 1996b; Lemmon et al., 1997) . In a variation on this theme, acidic fibroblast growth factor (aFGF) is monomeric when free, but oligomerizes when several molecules of aFGF bind to a single heparan sulfate proteoglycan (HSPG) molecule (SpivakKroizman et al., 1994) . The resulting (FGF) n -HSPG complex is multivalent in its binding to the FGF receptor, thus causing receptor oligomerization and activation (Spivak-Kroizman et al., 1994; Schlessinger et al., 1995) . The mechanism of epidermal growth factor (EGF) receptor activation by its ligands, including EGF, is less clear despite being the first receptor tyrosine kinase for which dimerization was shown to be the key activating step (Yarden and Schlessinger, 1987a,b) . EGFR binds to, Fig. 1 . SAXS data obtained for EGF at 8.7 mg/ml (1.36 mM), and can be activated by, a number of different ligands of represented in the form of a Guinier plot. The intensity of scattered radiation (I) was normalized using the mass concentration of EGF (c).
the EGF family, including EGF, transforming growth Ln (I/c) is plotted against Q 2 , where Q ϭ 4π sinθ/λ; λ is the factor-α (TGF-α), heparin binding EGF-like growth factor wavelength of the X-ray radiation and 2θ is the scattering angle. The (HB-EGF) (Higashiyama et al., 1991) , betacellulin (Shing scattered intensity at zero angle, I(0), which is proportional to the et al., 1993), amphiregulin (Plowman et al., 1990 ) and molecular mass of the protein, is obtained from the y-intercept (when epiregulin (Toyoda et al., 1995) . Binding and activation Q ϭ 0). By comparison with I(0)/c values measured for chymotrypsin, this experiment gave a molecular mass of 6.1 (Ϯ 0.6) kDa for EGF, in of the receptor by EGF has been most thoroughly studied.
good agreement with the value predicted for monomeric EGF from its EGF is presumed to be monomeric, and has been reported amino acid composition (6.2 kDa). The slope of the linear region of to bind to its receptor in a 1:1 complex (Weber et al., the Guinier plot is equal to (R G ) 2 /3, giving an R G for EGF of 11.5 1984; Günther et al., 1990) . These observations indicate (Ϯ 0.44) Å, consistent with its known elongated structure. SAXS experiments performed at two other lower EGF concentrations gave that the mode of EGF-induced receptor dimerization may similar results, showing that intermolecular interaction effects were not be different from that seen with the other receptors apparent at the EGF concentrations studied. mentioned here. Certainly, ligand bivalence cannot necessarily be assumed given the reported stoichiometry. Here we report studies of EGF binding to the EGF receptor Oligomeric state of EGF A key initial question in considering the mechanism extracellular domain (sEGFR), as well as the resulting quantitative dimerization of this domain, using a variety of ligand-induced growth factor receptor dimerization concerns the oligomeric state of the ligand itself. Although of biophysical techniques. The results obtained from the different experimental approaches suggest a model that it is generally assumed that EGF is monomeric in solution, quantitative demonstration of this has not, to our knowcan explain previous, apparently conflicting, results reported for this system. The best model differs from that ledge, been reported under conditions applicable to biophysical analysis of ligand-induced receptor dimerization. for the induction of receptor dimerization by hGH (Wells, 1996) in that sEGFR dimerization requires the participation We therefore used SAXS to determine the oligomeric state of EGF in solution at several different concentrations. The of two molecules of monomeric EGF (in a 2:2 dimer), and involves the dimerization of a stable intermediate 1:1 concentration-normalized intensity of forward scatter, I(0), estimated in a SAXS experiment is proportional to the EGF-sEGFR complex. No direct evidence was obtained for formation of a 1:2 EGF-sEGFR complex. The dimerizweight-averaged molecular mass of molecules in a solution scattering sample. Using well-characterized proteins as ation model that we propose provides a context for understanding the ability of different EGF-like ligands to standards, SAXS can be used to determine molecular mass. EGF was thus found to occur in solution as a induce heterodimerization of the EGFR family of receptor tyrosine kinases (Lemmon and Schlessinger, 1994) . monomeric species of 6.1 (Ϯ 0.6) kDa (Figure 1 )-in good agreement with its predicted monomeric molecular mass (6.2 kDa)-at three different concentrations up to
Results and discussion 8.7 mg/ml (1.36 mM). Intermolecular interaction effects were not evident, showing that EGF is monomeric in all The extracellular domain of the EGF receptor (sEGFR) was produced by secretion from CHO cells, and was of the experiments reported here. purified from conditioned medium as described (Lax et al., 1991a) . EGF binding to sEGFR, as well as to fragments Binding of EGF to sEGFR A number of studies of EGF binding to sEGFR have been of this domain, was studied by isothermal titration calorimetry (ITC). sEGFR dimerization upon EGF binding was reported (Greenfield et al., 1989; Günther et al., 1990; Hurwitz et al., 1991; Lax et al., 1991a; Zhou et al. , also analyzed using small-angle X-ray scattering (SAXS) and chemical cross-linking approaches. Quantitative 1993; Brown et al., 1994) . These reports differ in their conclusions regarding the ability of EGF to induce sEGFR dimerization of sEGFR was observed upon stoichiometric binding of EGF, and the data obtained were used to dimerization, but agree relatively closely in the measured K D values for EGF binding, which range from 100 to develop an equilibrium model of this event that initiates EGFR signaling. 500 nM. To determine directly the stoichiometry of this et al., 1996a ), aFGF (Spivak-Kroizman et al., 1994 and SCF (Philo et al., 1996b; Lemmon et al., 1997) , where ligand binding is enthalpy driven. The titration in Figure 2 also shows that the final stoichiometry of EGF binding to sEGFR is 1:1. Such 1:1 complexes are also formed by aFGF (Spivak-Kroizman et al., 1994) and SCF (Philo et al., 1996b; Lemmon et al., 1997) with their respective receptors, while hGH and EPO both form 1:2 (ligand:receptor) complexes (Cunningham et al., 1991; Philo et al., 1996a) . Table I A further feature specific to EGF is seen in the shape of the titrations (Figure 2 ). ITC studies of receptor binding by hGH (Cunningham et al., 1991) , aFGF (SpivakKroizman et al., 1994) and SCF (Philo et al., 1996b; Lemmon et al., 1997) occur at an EGF:sEGFR ratio of 1:2. However, the SAXS experiments described below show this prediction to be binding, and to analyze the thermodynamics of EGF wrong, arguing that the ITC data reflect multiple interacting binding to sEGFR, we employed ITC. The titrations (rather than independent) sites. By combining the results (Figure 2 ) allow several clear statements to be made about from both our SAXS and ITC analyses, we develop below EGF binding to sEGFR. Since heat is absorbed throughout an EGF binding model that is consistent with all of these the titrations, the overall enthalpy of binding (∆H) at 25°C experimental observations. is positive and hence unfavorable. The net free energy of binding in this endothermic reaction is therefore derived EGF-dependent dimerization of sEGFR from the entropy of binding. This contrasts with receptor
The simplest (two independent sites) model suggested by ITC studies of EGF binding to sEGFR predicted that binding by hGH (Cunningham et al., 1991) , EPO (Philo et al., 1991; Lax et al., 1991a) and sedimentation equilibrium centrifugation experiments (Brown et al., 1994) indicated only a modest degree of sEGFR dimerization upon ligand binding, with some formation of higher order oligomers (Lax et al., 1991a) . Density gradient centrifugation studies, performed at the significantly lower protein concentrations commonly used for EGF binding studies, showed no EGF-induced dimerization of sEGFR (Weber et al., 1984; Greenfield et al., 1989) . Furthermore, we could not detect EGFinduced sEGFR dimerization using size-exclusion chromatography (which may simply reflect a small differ- a shape-independent manner. To achieve this, the X-ray mass (M w ) of the particles in the sample solution (regardless of their shape). SAXS analysis of sEGFR alone showed that it does not self-aggregate significantly at above, which requires that maximal sEGFR dimerization occurs at an EGF:sEGFR ratio of 0.5. EGF and TGF-α concentrations up to 100 µM, and the measured I(0) was consistent with its expected monomeric molecular mass.
therefore differ from hGH in their mode of ligand-induced receptor dimerization. However, as EGF was titrated into a solution of sEGFR, I(0) (and therefore M w ) increased significantly ( Figure 3 ).
The SAXS analysis shows that the simplest interpretation of the ITC data presented above is inadequate, so This increase in M w was maximal (2.2-fold) at an [EGF] Tot-:[sEGFR] Tot ratio of 1:1, beyond which no further increase multiple interacting binding events must be considered. Conversely, the most straightforward interpretation of the was observed with additional EGF (up to a 5-fold molar excess). Similar results were obtained in more limited SAXS analysis alone would predict simple sigmoidal titrations in our ITC studies, similar to those seen for SCF studies of sEGFR dimerization induced by TGF-α binding (data not shown). Since the molecular mass of sEGFR is binding to the Kit extracellular domain (Philo et al., 1996b; Lemmon et al., 1997) . Figure 2 shows that this is110 kDa, while that of EGF or TGF-α is just 6.2 kDa, doubling of M w can only occur if the EGF-sEGFR not the case. By analyzing the data in more detail, we therefore sought to develop a straightforward model for complex involves an sEGFR dimer. Dimerization is complete under the conditions of this experiment, and there EGF-induced sEGFR dimerization that is consistent with the results from both our ITC and SAXS experiments, as is no evidence for the formation of higher order oligomers. The I(0) values reported here were normalized only by well as results previously reported for this system by others. Development of this model was aided by additional the mass of sEGFR, which was constant: the fact that I(0) does not increase further at [EGF] Tot : [sEGFR] Tot ratios experiments in which we have analyzed EGF binding to an isolated subdomain from sEGFR. greater than 1:1 shows that excess EGF remains free in solution. These experiments, therefore, provide additional support for the final 1:1 stoichiometry determined in the Binding of EGF to an isolated subdomain from sEGFR ITC studies. They also demonstrate that sEGFR dimerizes quantitatively in an EGF-dependent manner. The monoPrevious studies suggest that EGF can bind to sEGFR in the absence of sEGFR dimerization, with a K D in the tonic increase of I(0) to a maximum at a stoichiometry of 1:1 suggests a model for EGF-induced sEGFR dimerizrange 100-500 nM (Greenfield et al., 1989; Günther et al., 1990; Hurwitz et al., 1991; Lax et al., 1991a; Zhou et al. , ation in which one EGF molecule must bind to each molecule of sEGFR in order to induce dimerization (Figure 1993; Brown et al., 1994) . As a starting point in developing a model for EGF-induced sEGFR dimerization, we 3). This is clearly inconsistent with the simple multiple independent site interpretation of the ITC results outlined assumed a K D in this range for the formation of a 
Simple sigmoidal titrations were obtained, showing that a single class of sites exists. EGF forms a 1:1 complex with sEGFRd3, in an exothermic reaction (∆H ϭ -2 Ϯ 0.8 kcal/ mol), with an average K D of 480 Ϯ 186 nM. Since the small ∆H of this interaction made it difficult to measure a precise K D , surface plasmon resonance studies were also performed, which gave a similar value for K D , of 440 nM (data not shown). We were not able to detect sEGFRd3 dimerization upon EGF binding either in gel filtration or chemical cross-linking experiments (data not shown), suggesting that the K D value measured here reflects interaction of EGF with an sEGFRd3 monomer. The K D value is very similar to that reported for EGF binding to sEGFR in several studies (Greenfield et al., 1989; Günther et al., 1990; Hurwitz et al., 1991; Lax et al., 1991a; Zhou et al., K D as EGF binding to isolated domain 3. This agreement supports the finding that domain 3 is the primary site of interaction between EGFR and EGF (Lax et al., 1989) 1:1 EGF-sEGFR complex. The particular value that we employed was measured in studies of EGF binding to an and argues that interactions with EGF that involve other portions of sEGFR, if they occur, are weak. In developing isolated subdomain of sEGFR (domain 3) that is incapable of ligand-induced dimerization.
a model for EGF-induced sEGFR dimerization, we will therefore assume that this K D (µ400 nM) is valid for EGF The 621 amino acid extracellular domain of EGFR can be divided into four subdomains (1-4 from the N-to binding to the sEGFR monomer to form a 1:1 complex. We have not been able to generate isolated domain 1 C-termini) on the basis of amino acid sequence homology (Lax et al., 1988a,b) . Subdomains 2 (residues 160-310) from sEGFR to determine its independent EGF binding characteristics. However, while previous studies suggest and 4 (residues 475-621) are cysteine rich, with a pattern of conserved cysteines that resembles the structural motif that domain 1 does interact with EGF, it appears to do so much less strongly than domain 3 (Lax et al., 1990 , found in the TNF receptor extracellular domain (Ward et al., 1995) . Subdomains 1 (residues 1-160) and 3 1991b; Woltjer et al., 1992) . (residues 310-475) share 37% sequence identity (Lax et al., 1988a) , and have both been implicated in EGF How does EGF induce sEGFR dimerization? Using the facts that neither EGF nor sEGFR dimerize binding in experiments involving domain deletion, interspecies domain swapping and affinity cross-linking (Lax independently , that EGF forms a 1:1 monomeric complex with domain 3 of sEGFR (K D µ400 nM) and that EGF et al., 1989 EGF et al., , 1991b Wu et al., 1990; Woltjer et al., 1992) . Domain 3 itself has also been isolated from sEGFR using binding can induce complete sEGFR dimerization under appropriate conditions, we have developed an equilibrium limited proteolysis (Kohda et al., 1993) , arguing that it is an independently folded domain, which may also be thermodynamic model for EGF-induced sEGFR dimerization. As will be described, this model is consistent with true for the other subdomains. The domain 3 fragment (sEGFRd3), containing amino acids 302-503 of EGFR, all of our studies, as well as those presented elsewhere in the literature. Following the approach of Levitzki and was shown to bind TGF-α with a K D of~1 µM, but not to dimerize upon TGF-α binding (Kohda et al., 1993) . Schlessinger (1974) and Wofsy et al. (1992) , the equilibria describing each possible two-species binding event can Using ITC, we analyzed EGF binding to sEGFRd3, for which a representative titration is shown in Figure 4 . be written (see Table II ) for a case in which the ligand (L) does not self-associate (as demonstrated for EGF). A with K α and K 1 fixed as described above), the above equations can be used to calculate the change in M w subset of these equilibria can describe completely any model for dimerization of sEGFR (R) upon binding of predicted by the model as EGF is added. The molecular mass of sEGFR (M R ) is~110 kDa, and that of EGF (M L ) EGF (L).
The intrinsic binding and dimerization constants (equal is 6.2 kDa. The absolute value of I(0) abs measured in a SAXS experiment is proportional to Σn i M i 2 , for all values to 1/K D ) that describe these events are interdependent, and only four of the six described in Table II are required of i, where there are i species that have molar concentration n i and molecular mass M i . I(0) values determined in this to describe the system completely (if the nature of the product is assumed to be independent of the way it is study were normalized using only the mass concentration of sEGFR (ϭ [R] Tot ϫM R ): the added EGF was neglected. formed). The four equilibria that we consider can be chosen, based upon experimental accessibility, to minimize Therefore, the normalized I (0) Figure 5 , is then: 
With [R] Tot fixed at 65 µM, Equation 10 was used to
calculate the expected behavior of I(0) LTot as the ratio of
[L] Tot to [R] Tot was increased in the scattering samples.
This fitting procedure was first performed for a series of values of K γ , with K β ϭ 1 and K 1 ϭ 2.5ϫ10 6 M -1 (for
[R] 2 reasons described above). The fits were found to be
completely insensitive to variations in K α within the limits (K α ഛ500 M -1 ) defined above. K γ respectively. Figure 5 shows the level of agreement between model calculations using these K β and K γ values The SAXS experiments described above provide a monitor of changes in the weight-averaged molecular mass and the SAXS data. χ 2 for the best fit is 0.0941, with 20 degrees of freedom. Figure 5 also gives a view of the (M w ) of the species in solution as the [EGF] Tot :[sEGFR] Tot ratio is increased. To assess the agreement between the sensitivity of the fit to variations in K γ ( Figure 5B ) and K β ( Figure 5C ). Although the SAXS experiment was experimental SAXS data and any model proposed for EGF-induced sEGFR dimerization (defined by K β and K γ , performed under conditions close to an end-point titration, it is clear that a 5-fold increase in either binding constant leads to an inferior fit. Similarly, a 5-fold decrease in K γ (Figure 7) . (v) The RL complex can be considered as the primary intermediate in the formation of R 2 L 2 , which is the only form of sEGFR dimer that occurs to a significant extent under the conditions studied.
EGF-induced dimerization of sEGFR shows a concentration dependence that can account for its occurrence in the cell membrane
The model presented here provides an explanation for the varying ability of others to detect EGF-induced sEGFR dimerization. Figure 7 shows how RL, R 2 L, R 2 L 2 and R 2 [R] Tot ϭ 6.5 nM to model the interactions at concentrations commonly used in EGF binding assays for sEGFR (Lax et al., 1991a [R] Tot must be at least several micromolar the only two binding events that occur to a significant extent according to the model (see below). The value for for significant sEGFR dimerization to be detected, since the K D for dissociation of R 2 L 2 (1/K γ ) is µ3.3 µM. Indeed, the ∆H component of K 1 that gives the best fit to the ITC data is equal to ∆H for EGF binding to sEGFRd3, lending where significant sEGFR dimerization was reported previously, experiments were performed at concentrations further confidence to this fit. The prediction using these parameters is compared with the experimental ITC data ranging from 2 to 170 µM (Hurwitz et al., 1991; Lax et al., 1991a; Brown et al., 1994) , while reports in which in Figure 6A ; note that the heat per injection (as opposed to cumulative heat) is plotted against the [EGF] Tot :[sEGFR] Tot sEGFR dimerization was not detected employed density gradient centrifugation with final sEGFR concentrations ratio. As mentioned above, reversed titrations of sEGFR into a solution of EGF gave very similar curves. By ranging from 0.1 to 0.5 µM (Greenfield et al., 1989; Günther et al., 1990) . Unlike sEGFR, intact EGFR in a cell membrane is restricted to diffusion in two, rather than three, dimensions. predicted using the same ∆H values and other parameters ( Figure 6B ). Although the precision of the agreement EGFR also has at least one degree of rotational freedom less than the soluble ligand binding domain. As a result, between predicted and experimental data is poorer than that in Figure 6A , the shape of the titration is clearly dimerization of EGF-bound EGFR in a cell membrane will be a significantly more favorable reaction than dimerreproduced. The poorer agreement may result in part from errors in measuring [sEGFR] (Ͼ20 mg/ml) in the solution ization of the EGF-sEGFR complex studied here. Most cells that respond mitogenically to EGF contain~10 4 -10 5 used for this single titration.
receptors per cell. By considering the mean distance between receptor molecules, and translating this from a Elements of a model for EGF-induced sEGFR dimerization two-dimensional (membrane) to a three-dimensional case, these numbers correspond to effective receptor concentraAs shown in the previous section, the model represented by the equilibrium constants listed in Table III can predict tions of~1-10 µM (Schlessinger, 1979) . As described above, significant EGF-induced sEGFR dimerization adequately the results obtained from both our ITC and SAXS experiments. The main features of this model are occurs at these concentrations, arguing that our estimated value for K γ is sufficient to account for EGF-induced as follows. (i) sEGFR does not dimerize significantly in the absence of EGF. (ii) EGF binds to monomeric sEGFR EGFR dimerization at the cell surface. The additional orientational restrictions of EGFR molecules in the cell with a K D (1/K 1 ) of 400 nM, to form the RL complex. (iii) RL may interact weakly (K D ϭ 1/2K β µ50 µM) with membrane will favor the energetics of EGF-induced dimerization still further. Thus, our model does not require that another receptor molecule to yield the R 2 L complex, but this species does not accumulate significantly under the additional interactions involving the transmembrane and cytoplasmic domains of intact EGFR be invoked in stabilconditions explored here (Figure 7) . (iv) RL associates much more readily with a second molecule of RL (K D ϭ izing the ligand-induced dimer, although it is likely that these regions will contribute, perhaps significantly. If the 1/K γ µ3.3 µM) to yield the R 2 L 2 dimer. This species effective concentration of EGFR in the cell membrane is Binding of EGF to purified, detergent-solubilized, intact EGFR at low concentration also gives linear Scatchard significantly greater than 1/2K β (50 µM), then significant occurrence of the 1:2 EGF-EGFR dimeric complex would plots (Yarden et al., 1985; Yarden and Schlessinger, 1987a) , and yields K D values (µ1/K 1 ) similar to those also be predicted by our model, particularly if transmembrane and cytoplasmic portions of the receptor contribute obtained in studies of sEGFR. By contrast, Sherrill and Kyte (1996) , in a detailed study of EGF binding to EGFR to dimerization. Thus, although we obtained no direct evidence for the occurrence of a 1:2 dimer, its occurrence purified from detergent extracts of A431 cells, clearly observed a sigmoidal binding curve characterized by a is not excluded by our model.
Hill constant of 1.7 Ϯ 0.5, which agrees closely with the maximum value predicted by our model. We suggest that Cooperativity in EGF binding to sEGFR The model defined by the binding constants listed in Table these differences reflect differences in receptor concentration, and that positive cooperativity will be seen when the III clearly involves cooperativity in EGF binding to sEGFR under conditions where the R 2 L 2 dimer is formed.
effective EGFR concentration is greater than~250 nM. There is one observation for EGF binding to EGFR Simulated Scatchard plots are concave-down, indicating positive cooperativity, when [R] Tot is Ͼ250 nM (corresthat cannot be explained by our model. Scatchard analysis of EGF binding to cell membranes that contain EGFR ponding to the concentrations used for SAXS, ITC and chemical cross-linking experiments). The maximum preusually yields concave-up plots, which are ascribed to heterogeneity in the binding affinities of the receptors dicted Hill constant at 50% saturation is 1.5 under the conditions of the SAXS experiments, falling to 1.1 when (Berkers et al., 1991) . In most cases, it is assumed that this Scatchard plot curvature reflects the existence of [R] Tot ϭ 250 nM. Simulated Scatchard plots are linear for [R] Tot values below 250 nM, in agreement with the two (or more) different affinity classes of the receptor (Schlessinger, 1988) . It has been difficult to determine the lack of apparent cooperativity in studies reported in the literature (Greenfield et al., 1989; Günther et al., 1990;  precise origin of this behavior. The degree of curvature seen in the binding curves varies between reports. It has Hurwitz et al., 1991; Lax et al., 1991a; Zhou et al., 1993; Brown et al., 1994) . All of these studies employed also been found to be altered upon various treatments of the cell with, for example, activators of protein kinase C sEGFR concentrations from 5 to 20 nM, where no sEGFR dimerization occurs, and the apparent K D reflects only K 1 , (Schlessinger, 1988) that may lead to 'transmodulation' of the receptor's binding affinity. Efforts to generate an since RL is the only species that forms. equilibrium binding model that can adequately account for the concave-up plots seen for EGF binding to crude cell membranes have not been successful (Wofsy et al., 1992) . Rather, additional sources of receptor heterogeneity (or even additional EGF binding sites) must be invoked in order to explain the data. The effects of receptor 'transmodulation' by enzymes such as PKC, which may alter EGF binding affinity, would not be accessible to the approaches used in this study. Another possible source of heterogeneity is heterodimerization of EGFR with other erbB receptor family members (see below). Whether interactions between the extracellular domains of these different receptors can explain the observed concave-up Scatchard plots seen for EGF binding to cell membranes is an interesting question that can be addressed using the approaches employed here.
To our knowledge, with the limitation that we cannot explain the Scatchard plots obtained for EGF binding to intact cells (which may reflect heterogeneities in the environment of the cellular receptor), the model that we describe here (Table III) is consistent with all previously reported studies of EGF binding to, and activation of, EGFR.
Dimensions of sEGFR monomers and dimers
In addition to molecular mass information, SAXS also provides information on changes in molecular dimensions that accompany sEGFR dimerization. Figure 8A shows how the radius of gyration (R G ) increases as the [EGF] Tot :
[sEGFR] Tot ratio is increased. R G for the unliganded sEGFR is 35.7 Å, which increases as EGF is added, following roughly the same trend as seen for I(0). R G reaches a maximum value of~44 Å for the R 2 L 2 complex. Using these R G values for monomeric and dimeric sEGFR respectively, we checked that the model defined above can predict adequately the observed increase in R G as the 3. Points represent the R G for a given experiment at a particular As seen in Figure 8A , the fit is reasonably good.
[EGF] Tot :[sEGFR] Tot ratio, with associated errors from least-squares Assuming that~35% of the mass of the 110 kDa sEGFR linear fitting of the Guinier plot. The line through the points represents the predicted R G according to the model defined by the binding monomer is carbohydrate, its volume can be estimated at constants in Table III radial Patterson, or pair-distance distribution, function [P(r)] that is derived by Fourier inversion of the scattering data ( Figure 8B ). The P(r) curve represents the length The relative d max values for the monomer and dimer suggest that the sEGFR dimer is approximated by a pair distribution of interatomic vectors in the molecule of interest, which will be a single distribution for a globular of oblate ellipsoids with the dimensions described above, associated with their long axes parallel. protein. Both sEGFR and the R 2 L 2 complex give such a single distribution, indicating that the two sEGFR molecules are intimately associated in the dimeric complex.
Implications for EGF-induced EGFR dimerization
As discussed above, the model for EGF-induced sEGFR The value for d max , or longest interatomic distance in the distribution, is very similar for both monomeric and dimerization involves formation of a 1:1 EGF:sEGFR (RL) complex (K D ϭ 1/K 1 µ400 nM), followed by dimeric sEGFR: 110 and 120 Å respectively. This result may explain our failure to distinguish between momomeric dimerization of this complex with a
The magnitudes of these equilibrium constants are suffiand dimeric sEGFR in size-exclusion chromatography. Fig. 9 . A scheme depicting the proposed model for EGF-induced dimerization of sEGFR. EGF binds to a monomer of sEGFR (through interactions involving primarily domain 3) with K D µ400 nM, to form a 1:1 EGF-sEGFR complex (RL). RL then dimerizes with a K D of~3.3 µM to form the R 2 L 2 dimeric complex. EGF is shaded black and sEGFR gray. Two possibilities for RL dimerization are presented, with a schematic view from the top of the receptor (the membrane would be in the plane of the page). In one possibilitiy (A), RL dimerization is mediated primarily by interactions involving EGF (ligand-mediated). EGF binds to domain 3 on each of the two sEGFR molecules, leaving its putative domain 1-interacting site unoccupied. Dimerization of RL could then be driven by cooperation of two EGF-domain 1 interactions, with a possible additional contribution from direct inter-receptor interactions (shown by contact between the two receptors). In (B), the other possibility (receptor-mediated), EGF binding (to domain 3) results in conformational changes that expose a receptor-receptor interaction site. RL can interact significantly only with another RL complex through this dimerization site, to yield the R 2 L 2 dimer. cient to explain EGF-induced EGFR dimerization of the a K D for EGF binding to domain 1 alone of~1.8 mM. A binary interaction of this strength would not have been cell surface without requiring a role for other portions of the whole receptor. Formation of the R 2 L complex, in detected in any of the studies presented in the literature. Receptor-receptor interactions would probably contribute which a single ligand molecule stabilizes the sEGFR dimer, is not predicted to be significant except at the very further to stabilization of the dimer, but the primary driving force would be simultaneous bivalent binding of highest sEGFR concentrations (which could occur at the cell surface), and we obtained no direct evidence for its two EGF molecules. Dimerization of sEGFR by a single EGF would only involve a single EGF-domain 1 interoccurrence. As depicted in Figure 9 , two possible modes for dimerization of the RL complex can be envisaged. At action, and would occur only at very high effective receptor concentration. The value for K β in our model one extreme ( Figure 9A ), dimerization is mediated by the bound ligand molecules (ligand-mediated), and at the (Table III) , together with consideration of both the effective concentration of EGFR at the cell surface and the rotational other by receptor-receptor contacts stabilized through ligand-induced conformational changes (receptor-medirestrictions on the membrane-bound receptor, argues that this event is unlikely, but cannot be excluded. ated) ( Figure 9B) . It is not possible to distinguish between these possibilities from our studies, and the reality is One appeal of the scheme in Figure 9A is that it does not require major conformational changes in the receptor, likely to lie somewhere between the two extremes. There are several arguments, however, that can be made in favor such as may be required to create the receptor-receptor interaction site depicted in Figure 9B . Studies employing of the ligand-mediated proposal. The key argument is that the thermodynamics of EGF binding to monomeric sEGFR circular dichroism and fluorescence measurements indicate that the conformational alterations elicited by EGF binding are very similar to those describing EGF binding to isolated domain 3. If ligand-induced conformational changes were are limited in extent (Greenfield et al., 1989) . Distinction between the two possibilities presented in Figure 9 will major, a greater difference might be expected when subdomains 1, 2 and 4 are removed by proteolysis. Domain require structural studies of the complex. Determination of the crystal structure of the complex, which has not 1 of sEGFR shares 37% amino acid identity with domain 3, and has also been implicated in EGF binding by affinity yielded after a decade of effort by many groups, would be invaluable. cross-linking studies (Lax et al. 1988a; Woltjer et al., 1992) . It is possible that domain 1 contributes weakly to EGF binding to monomeric sEGFR, and we cannot detect Possible implications for heterodimerization of erbB receptors its removal since interactions with domain 3 predominate. However, it is equally possible that, as proposed in Figure The ligand-mediated model ( Figure 9A ), in which EGF is bivalent, suggests a possible mechanism by which EGF 9A, an EGF molecule bound to domain 3 of one sEGFR molecule interacts with domain 1 of its partner in the and the other seven (or more) different members of the EGF-like family of growth factors can induce heteroligand-stabilized dimer. With K γ ϭ 3ϫ10 5 M -1 , the energy stabilizing RL dimerization is~7.5 kcal/mol. In the liganddimerization of different erbB receptors Hynes and Stern, 1994 ; Lemmon and mediated scheme of Figure 9A , each EGF-domain 1 interaction could contribute 3.75 kcal/mol, equivalent to . EGF itself has been shown to induce the formation of heterodimers between EGFR and erbB2 bivalent ligand moieties for ligand-induced dimerization. Each EGF molecule would bind asymmetrically to the (King et al., 1988; Stern and Kamps, 1988; Qian et al., 1992; Spivak-Kroizman et al., 1992) . This case has been EGFR dimer, contacting one receptor through a highaffinity site (domain 3), and the other through a lowrecapitulated with the extracellular domains alone of erbB2 and EGFR (Spivak-Kroizman et al., 1992) . Heterodimerizaffinity site (domain 1), thus broadly resembling hGH in their mode of association with the complex. Indeed, the ation of EGFR with erbB3 (Soltoff et al., 1994) , and erbB4 (Cohen et al., 1996) is also thought be induced by model presented in Figure 9A resembles a symmetrical version of the sequential mechanism proposed for hGH-EGF, and the heregulins are thought to induce the formation of other heterodimers involving erbB3 and/or erbB4 (Riese induced dimerization of hGH-R (Wells, 1996) . Given this similarity, we favor the ligand-mediated mechanism over et al ., 1995) . It has also been found that heregulin and EGF binding are mutually antagonistic to cells that express the receptor-mediated mechanism for EGF-induced dimerization of sEGFR. both EGFR and erbB4, despite the fact that EGF binds only to EGFR and the heregulin binds only to erbB4
Finally, Sherrill and Kyte (1996) recently described detailed studies of EGF-induced dimerization and activ- (Karunagaran et al., 1995) . If EGF and the other EGF family members are bivalent as depicted in Figure 9A , ation of intact detergent-solubilized EGFR as a function of both EGF and receptor concentration. From their heterodimerization could result from their simultaneous binding to two erbB receptors. EGF, TGF-α, HB-EGF, studies, the model developed for EGF-induced receptor activation agrees remarkably well in its characteristics amphiregulin, betacellulin and epiregulin might all bind similarly to domain 3 of EGFR, but might differ in their with the model that we have described here. The actual values estimated for the equilibrium constants are different proposed domain 1 binding region. Each would then be expected to induce a distinct complement of erbB between the two models. This is expected, since one study was performed with whole EGFR restricted to detergent heterodimers. Indeed, the pattern of responses elicited by each of these ligands, in a given cell type that expresses micelles, while the other (presented here) was performed with sEGFR, which has additional rotational and translamultiple erbB receptors, has been found to be different in detail (Beerli and Hynes, 1996; Riese et al., 1996) . A tional degrees of freedom. One requirement of the model described by Sherrill and Kyte (1996) , which was not bivalent mode of ligand interaction is also suggested by the report that substitution of the amino-terminus of EGF addressed in our studies, is that, if the R 2 L complex does occur to a significant extent, it is not activated. This by that from heregulin-β generates a bifunctional ligand that binds both EGFR and erbB3/4 (Barbacci et al., 1995) .
finding further argues that formation of the R 2 L 2 complex described here is the key event in EGFR signaling. Betacellulin is also bifunctional, binding both EGFR and erbB4 (Riese et al., 1996) . Such bifunctional ligands are likely to induce heterodimerization of EGFR with erbB4,
Materials and methods
and are likely to do so via bivalent interactions. Further
Production of sEGFR and sEGFRd3
detailed studies of ligand binding to, and hetero-and sEGFR was produced by overexpression in CHO cells, as previously homodimerization of, erbB family extracellular domains described (Lax et al., 1991b) . sEGFR was purified from conditioned are required. One such study has been reported for the medium by immunoaffinity chromatography employing mAb 108, a monoclonal antibody against the extracellular domain of EGFR. sEGFR extracellular domains of erbB2 and erbB3, using analytical was eluted from the immunoaffinity column and further purified essenultracentrifugation (Horan et al., 1995) . Neither heregulintially as described (Lax et al., 1991b) . sEGFR contains residues 1-621 induced homodimerization of erbB3 nor erbB2-erbB3 of the mature receptor. sEGFRd3 was prepared from purified sEGFR by heterodimerization could be detected. The erbB3 extralimited proteolysis with proteinase K, as described (Kohda et al., 1993) . cellular domain formed a 1:1 monomeric complex with The resulting~35 kDa (glycosylated) fragment includes residues 295-505 of EGFR, including the complete subdomain 3 as originally defined heregulin β2. These studies were performed at significantly by Lax et al. (1988b) , which encompasses residues 310-474. The identity lower concentrations (6 µM) than those employed in our of the products in each case was confirmed by N-terminal sequencing studies of sEGFR, and may not adequately account for and quantitative amino acid analysis. Purified recombinant EGF (human) the difference in diffusional freedom between the twowas purchased from Intergen (New York, USA). Purified recombinant TGF-α was purchased from Bachem (Basel, Switzerland). Molar extincdimensional (membrane-bound) and three-dimensional tion coefficients (at 278 nm) were determined by quantitative amino (free in solution) cases.
acid analysis of aliquots of protein solutions with known absorbance. The values determined were as follows: sEGFR, 58 500 M -1 cm -1 ;
Comparison with ligand-induced dimerization of sEGFRd3, 17 100 M -1 cm -1 ; hEGF, 14 400 M -1 cm -1 ; TGF-α, other receptors 1500 M -1 cm -1 .
As described in the Introduction, a common theme has
Isothermal titration calorimetry
emerged from studies of ligand-induced receptor dimerizAll ITC studies employed the Omega instrument (MicroCal, ation in which the ligand species is bivalent, and binds Northampton, MA; Wiseman et al., 1989) in the laboratory of Professor Julian Sturtevant (Department of Chemistry, Yale University). For each simultaneously to two receptor molecules. Studies of hGHtitration, both the sEGFR variant and EGF were dialyzed into the same induced dimerization of its receptor initiated this paradigm. reaction buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 3.4 mM EDTA).
The studies presented here for EGF-induced sEGFR Each titration was performed at 25°C. A typical titration (Figure 2) dimerization do not fit this paradigm precisely. EGF is a involved serial injections of 20ϫ10 µl aliquots of EGF (130 µM) into monomeric ligand that induces receptor dimerization by a solution of sEGFR (12 µM) in the calorimeter cell (volume 1.39 ml). For each case, control experiments were performed to determine the forming a 2:2 complex with its receptor. In the scheme heat of mixing of the components. Heats of mixing were constant of Figure 9 , the receptor-mediated possibility ( Figure 9B) throughout the titration, and the measured constant value was subtracted would make this a special case. The ligand-mediated from the heat per injection prior to analysis of the data. Data were proposal ( Figure 9A ), however, would make it a variation analyzed with ORIGIN software (MicroCal), using the fitting algorithms provided.
on the theme, requiring the binding of two, rather than one,
